Vitamin K2
The Vitamin K Cycle and Gamma-Glutamyl Carboxylation
Vitamin K2 (menaquinone) functions primarily as an enzymatic cofactor in the post-translational modification of specific proteins, a process essential for calcium homeostasis, blood coagulation, and cellular signaling. The core biochemical mechanism relies on the 'Vitamin K Cycle.' In the endoplasmic reticulum, Vitamin K2 is reduced to its active hydroquinone form (Vitamin K2H2) by the enzyme vitamin K epoxide reductase (VKOR). This reduced form serves as an essential cofactor for the enzyme gamma-glutamyl carboxylase (GGCX).
GGCX catalyzes the addition of a carboxyl group (CO2) to the gamma-carbon of specific glutamic acid (Glu) residues within target proteins, converting them into gamma-carboxyglutamic acid (Gla) residues. This carboxylation is an oxidation-reduction reaction where Vitamin K2H2 is simultaneously oxidized to Vitamin K epoxide. To sustain the cycle, Vitamin K epoxide must be recycled back to the active hydroquinone form by VKOR. This recycling process is the exact target of coumarin-derivative anticoagulants like warfarin, which inhibit VKOR, thereby halting the production of active Gla-proteins.
Activation of Osteocalcin (Bone Gla Protein)
One of the primary targets of Vitamin K2 is osteocalcin, a protein synthesized by osteoblasts (bone-building cells) during bone formation. In its uncarboxylated state (ucOC), osteocalcin has a weak affinity for calcium. When Vitamin K2 facilitates the carboxylation of its three specific glutamic acid residues, it undergoes a conformational change. This structural shift exposes the negatively charged Gla residues, allowing the protein to bind tightly to positively charged calcium ions and hydroxyapatite crystals in the extracellular bone matrix.
Clinical evidence demonstrates that Vitamin K2 supplementation significantly reduces the ratio of uncarboxylated to carboxylated osteocalcin, a recognized biomarker for bone health. By ensuring that osteocalcin is fully activated, Vitamin K2 ensures that circulating calcium is effectively integrated into the skeletal structure, thereby improving bone mineral density and reducing fracture risk, particularly in postmenopausal populations.
Activation of Matrix Gla Protein (MGP) and Vascular Health
While osteocalcin directs calcium into bone, Matrix Gla Protein (MGP) serves the critical function of keeping calcium out of soft tissues. MGP is synthesized by vascular smooth muscle cells and chondrocytes. It is widely recognized as the most potent endogenous inhibitor of vascular calcification. Like osteocalcin, MGP requires Vitamin K-dependent carboxylation to become biologically active.
When fully carboxylated, MGP binds to calcium crystals in the tunica media and intima of blood vessels, preventing their growth and deposition. It also binds to bone morphogenetic protein-2 (BMP-2), inhibiting the transdifferentiation of vascular smooth muscle cells into osteoblast-like cells—a primary driver of arterial stiffening. A deficiency in Vitamin K2 leads to high levels of inactive, uncarboxylated MGP (ucMGP), which is strongly correlated with increased arterial calcification, arterial stiffness, and cardiovascular mortality.
Pharmacokinetics: MK-4 vs. MK-7
Vitamin K2 exists in several isoforms, distinguished by the length of their isoprenoid side chains. The two most clinically relevant forms are Menaquinone-4 (MK-4) and Menaquinone-7 (MK-7), which exhibit vastly different pharmacokinetic profiles.
MK-4, containing four isoprene units, is highly lipophilic but has a very short half-life in circulation (approximately 1 to 2 hours). It is primarily transported by triglycerides and rapidly cleared by the liver and extrahepatic tissues. Because of its rapid clearance, MK-4 requires multiple daily doses or very high pharmacological doses (e.g., 45 mg/day) to achieve sustained therapeutic effects for bone health.
MK-7, containing seven isoprene units, is significantly more hydrophobic. After intestinal absorption via chylomicrons, MK-7 is redistributed by the liver into low-density lipoproteins (LDL) and high-density lipoproteins (HDL). This lipoprotein transport allows MK-7 to remain in circulation for an extended period, with a half-life of approximately 72 hours. This prolonged half-life results in a much larger area under the curve (AUC) and allows for steady-state serum levels to be achieved with a single, low daily dose (e.g., 90 to 375 mcg/day). The extended circulation of MK-7 also makes it highly bioavailable to extrahepatic tissues, particularly the vasculature, making it the preferred form for cardiovascular support.
Extrahepatic Functions and Emerging Pathways
Beyond calcium regulation, Vitamin K2 is involved in the activation of Growth Arrest-Specific 6 (Gas6) protein. Gas6 is a Gla-protein secreted by endothelial cells, leukocytes, and vascular smooth muscle cells. It binds to the TAM family of receptor tyrosine kinases (Tyro3, Axl, Mer), regulating cellular survival, proliferation, apoptosis, and inflammatory responses. Through Gas6 activation, Vitamin K2 exhibits neuroprotective, anti-inflammatory, and anti-apoptotic properties.
Furthermore, emerging biochemical research suggests that MK-4 may play a unique role in mitochondrial function. In certain cell types, MK-4 can act as an electron carrier in the mitochondrial electron transport chain, bypassing complex I and II to directly transfer electrons to cytochrome c. This mechanism may help rescue cellular ATP production in states of mitochondrial dysfunction, presenting a novel therapeutic pathway for neurodegenerative diseases and metabolic disorders.
What is the vitamin K2 supplement used for? +
Who should not take vitamin K2? +
Can vitamin K2 help with hypercalcemia? +
Does vitamin K2 help with hypertension? +
What medications should not be taken with vitamin K2? +
Who shouldn't take K2 supplements? +
What are the signs of too much vitamin K2? +
What should you not mix vitamin K with? +
What is the difference between MK-4 and MK-7? +
Should I take Vitamin K2 with food? +
Does Vitamin K2 help with dry eyes? +
Why is Vitamin K2 often paired with Vitamin D3? +
Can Vitamin K2 reverse arterial calcification? +
Is Vitamin K2 safe during pregnancy? +
Does Vitamin K2 reduce bruising? +
Can I get enough Vitamin K2 from my diet? +
What is the optimal dose for bone health? +
Everything About Vitamin K2 Article
The Silent Guardian of Calcium
For decades, calcium and Vitamin D have been the undisputed champions of bone health. However, modern clinical nutrition has uncovered a missing link in this equation: Vitamin K2. While Vitamin D ensures that you absorb calcium from your diet, it has no ability to control where that calcium goes. Without proper direction, circulating calcium can deposit in soft tissues, leading to arterial stiffening and cardiovascular disease—a phenomenon known as the "calcium paradox."
Vitamin K2 is the biological traffic cop for calcium. It activates specific proteins that bind calcium and integrate it into the bone matrix, while simultaneously activating other proteins that sweep calcium out of your arteries. Whether you are an athlete looking to fortify your skeletal system against heavy loads, or an aging adult aiming to protect your cardiovascular health, Vitamin K2 is a non-negotiable foundational nutrient.
How Vitamin K2 Works: The Biochemistry
To understand Vitamin K2, you have to understand a biochemical process called gamma-glutamyl carboxylation.
Inside your body, certain proteins are produced in an inactive state. Two of the most important are Osteocalcin (produced in your bones) and Matrix Gla Protein (MGP) (produced in your blood vessels). In their inactive states, these proteins cannot bind to calcium.
Vitamin K2 acts as a necessary cofactor for the enzyme that "carboxylates" these proteins. This chemical modification changes the physical shape of the proteins, giving them molecular "claws" that can grab onto calcium ions.
1. In the Bones: Activated osteocalcin grabs calcium from the blood and binds it to the hydroxyapatite matrix of the bone, increasing bone mineral density and strength. 2. In the Arteries: Activated MGP binds to free-floating calcium in the cardiovascular system, preventing it from crystallizing and forming plaques in the arterial walls.
Without adequate Vitamin K2, osteocalcin and MGP remain uncarboxylated and useless. Calcium is left to drift aimlessly, leading to weak bones and stiff arteries.
MK-4 vs. MK-7: Understanding the Forms
If you look at a supplement label, you will rarely just see "Vitamin K2." Instead, you will see Menaquinone-4 (MK-4) or Menaquinone-7 (MK-7). Understanding the difference between these two forms is critical for effective supplementation.
Menaquinone-4 (MK-4) MK-4 is found naturally in animal products like meat, dairy, and eggs. While it is biologically active, it has a major pharmacokinetic flaw: a very short half-life. MK-4 disappears from the bloodstream in just 1 to 2 hours. Because it is cleared so rapidly, clinical studies using MK-4 for bone health require massive pharmacological doses—typically 15 to 45 milligrams (mg) per day, often split into multiple doses.
Menaquinone-7 (MK-7) MK-7 is derived from bacterial fermentation, most notably found in the Japanese dish natto (fermented soybeans). MK-7 is highly lipophilic and is transported through the bloodstream via LDL and HDL cholesterol particles. This gives MK-7 an incredibly long half-life of approximately 72 hours. Because it stays in the blood for days, it can build up to steady-state levels with a single, very small daily dose. Clinical efficacy for MK-7 is achieved at just 90 to 375 micrograms (mcg) per day.
For general supplementation, MK-7 is vastly superior due to its long half-life, higher extrahepatic tissue distribution, and convenient once-daily microgram dosing.
Clinical Evidence: What the Science Says
According to the Examine.com database, which aggregates over 140 references and 24 clinical trials on Vitamin K, the evidence is robust in specific areas, while lacking in others.
Strong Evidence (Grade B) Bone Mineral Density: Across 13 studies involving over 1,000 participants, Vitamin K supplementation showed a moderate improvement in bone mineral density. This effect is particularly pronounced in osteoporotic patients and postmenopausal women. Liver Cancer Mortality: Meta-analyses of 9 studies (1,980 participants) show a small but statistically significant improvement in mortality rates specifically related to liver cancer.
Lack of Effect (Grade D) It is equally important to know what a supplement cannot do. Clinical data shows that Vitamin K2 does not: Reduce C-Reactive Protein (CRP) or systemic inflammation. Improve adiponectin levels or metabolic syndrome markers. Reduce bruising or accelerate surgical skin recovery. Lower blood pressure in patients with cardiovascular disease.
Optimal Dosing and Synergies
Based on clinical standards, the recommended dosage depends entirely on the form of K2 you are taking: For MK-7: 90 mcg to 375 mcg daily. For MK-4: 15 mg to 45 mg daily.
The Vitamin D3 Synergy: Vitamin K2 should almost always be paired with Vitamin D3. Vitamin D3 stimulates the body to produce more osteocalcin and MGP. However, D3 cannot activate these proteins. Taking high doses of D3 without K2 creates a surplus of inactive calcium-binding proteins. K2 is required to activate the proteins that D3 creates.
Take with Fat: Vitamin K2 is a fat-soluble vitamin. Taking it on an empty stomach will result in poor absorption. Always take your K2 supplement with a meal containing dietary fats (like eggs, avocado, or olive oil) to stimulate bile production and chylomicron formation.
Safety, Interactions, and Contraindications
Vitamin K2 is generally recognized as safe and does not have an established Upper Tolerable Limit (UL). However, it has severe, potentially life-threatening drug interactions.
The Warfarin Warning If you are taking Warfarin (Coumadin) or similar coumarin-derivative blood thinners, you must avoid Vitamin K supplements unless explicitly directed by your cardiologist. Warfarin works specifically by inhibiting the Vitamin K cycle to prevent blood clotting. Supplementing with Vitamin K directly antagonizes the medication, which can lead to rapid and fatal blood clots.
Absorption Blockers According to interaction data from Drugs.com, several medications can block the absorption of Vitamin K2. These include: Bile Acid Sequestrants: Cholestyramine, Colesevelam, Colestipol. Weight Loss Drugs: Orlistat (blocks dietary fat absorption). Laxatives: Mineral oil, bisacodyl, senna, castor oil. If you take any of these medications, you must separate your Vitamin K2 dose by at least 2 to 4 hours to ensure it is absorbed.
Hepatobiliary Dysfunction Individuals with liver or gallbladder issues (hepatobiliary dysfunction) may have impaired bile production. Because bile is required to absorb fat-soluble vitamins, these individuals may not effectively absorb oral Vitamin K2 supplements and should consult a physician.